Los Angeles Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-153,161
| Closed | -$9.68M | – | 2469 |
|
|
2025
Q4 | $9.68M | Sell |
153,161
-36,251
| -19% | -$2.91M | 0.03% | 233 |
|
|
2025
Q3 | $10.4M | Buy |
189,412
+54,414
| +40% | +$2.72M | 0.04% | 262 |
|
|
2025
Q2 | $7.17M | Buy |
+134,998
| New | +$6.86M | 0.03% | 272 |
|
|
2024
Q4 | – | Sell |
-62,062
| Closed | -$4.23M | – | 1158 |
|
|
2024
Q3 | $4.23M | Buy |
+62,062
| New | +$3.5M | 0.02% | 332 |
|
|
2024
Q2 | – | Sell |
-7,214
| Closed | -$498K | – | 1205 |
|
|
2024
Q1 | $498K | Sell |
7,214
-10,928
| -60% | -$691K | ﹤0.01% | 873 |
|
|
2023
Q4 | $1.34M | Buy |
+18,142
| New | +$1.19M | 0.01% | 576 |
|
|
2023
Q2 | – | Sell |
-5,640
| Closed | -$382K | – | 1206 |
|
|
2023
Q1 | $382K | Buy |
+5,640
| New | +$363K | ﹤0.01% | 937 |
|
|
2021
Q3 | – | Sell |
-1,899
| Closed | -$236K | – | 1509 |
|
|
2021
Q2 | $236K | Sell |
1,899
-2,060
| -52% | -$246K | ﹤0.01% | 1452 |
|
|
2021
Q1 | $522K | Sell |
3,959
-2,754
| -41% | -$377K | ﹤0.01% | 1201 |
|
|
2020
Q4 | $889K | Buy |
6,713
+3,592
| +115% | +$434K | ﹤0.01% | 989 |
|
|
2020
Q3 | $318K | Buy |
+3,121
| New | +$270K | ﹤0.01% | 1251 |
|
|
2020
Q2 | – | Sell |
-16,220
| Closed | -$941K | – | 1470 |
|
|
2020
Q1 | $941K | Hold |
16,220
| – | – | 0.01% | 725 |
|
|
2019
Q4 | $1.5M | Buy |
16,220
+12,335
| +318% | +$1.08M | 0.01% | 719 |
|
|
2019
Q3 | $351K | Sell |
3,885
-270
| -6% | -$30.8K | ﹤0.01% | 1087 |
|
|
2019
Q2 | $490K | Sell |
4,155
-51,402
| -93% | -$5.18M | ﹤0.01% | 1046 |
|
|
2019
Q1 | $4.81M | Buy |
55,557
+50,470
| +992% | +$4.3M | 0.03% | 444 |
|
|
2018
Q4 | $321K | Sell |
5,087
-210
| -4% | -$14.4K | ﹤0.01% | 1079 |
|
|
2018
Q3 | $418K | Sell |
5,297
-29,065
| -85% | -$1.9M | ﹤0.01% | 1149 |
|
|
2018
Q2 | $2.06M | Sell |
34,362
-44,820
| -57% | -$2.41M | 0.01% | 685 |
|
|
2018
Q1 | $3.19M | Buy |
79,182
+3,040
| +4% | +$148K | 0.02% | 522 |
|
|
2017
Q4 | $4M | Buy |
76,142
+56,887
| +295% | +$3.04M | 0.02% | 496 |
|
|
2017
Q3 | $907K | Buy |
+19,255
| New | +$775K | 0.01% | 844 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Los Angeles Capital Management's EXAS Position: Q1 2026 in Review
Los Angeles Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 153,161 shares — an estimated $9.68M sold.
Los Angeles Capital Management first reported a position in EXAS in Q3 2017 and held it in 22 quarters. The position peaked at $10.4M in Q3 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Los Angeles Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Los Angeles Capital Management sold 153,161 Exact Sciences shares in Q1 2026, an estimated $9.68M.
- Los Angeles Capital Management first reported a position in Exact Sciences in Q3 2017 and held it in 22 quarters.
- Los Angeles Capital Management's Exact Sciences position peaked at $10.4M in Q3 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.